January 9, 2020 – New research into the biology of depression, along with new and evolving technologies, provides the basis for developing the next generation of treatments for major depressive disorder (MDD), according to the special January/February issue of Harvard Review of Psychiatry. The journal is published in the Lippincott portfolio by Wolters Kluwer. “By…
Details
January 9, 2020 – Imagine living with unwanted sexual arousals, occurring unexpectedly and repeatedly, unrelated to any sexual desire or pleasure. That’s the situation for women with a rare and disabling condition called persistent genital arousal disorder (PGAD), according to a case series in PAIN Reports®, the official open-access journal of the International Association for…
Details
PHILADELPHIA – Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, announces lead monoclonal antibodies (MAbs) against P2X7, a structurally complex ion channel that is the target for autoimmune disorders including atopic dermatitis and glomerulonephritis. The panel of P2X7 antibodies is fully humanized and optimized, and ready to progress towards preclinical studies. The…
Details
PITTSBURGH (Jan. 9, 2020) … Neural stimulation is a pioneering technology that can be used to recover function and improve the quality of life for individuals who suffer from brain injury or disease. It serves an integral role in modern neuroscience research and human neuroprosthetics, including advancements in prosthetic limbs and brain-computer interfaces. A challenge…
Details
A new study shows that a test physicians commonly used to guide chemotherapy treatment for post-breast cancer surgery patients may also help them decide whether radiation therapy may be of benefit. Known as the 21-gene recurrence score, the test is a personalized analysis of the activity of 21 genes found in a patient’s breast tumor…
Details
Low-income people with addiction, especially those with addiction to opioids, may find it hard to access the kind of care they need to recover no matter where they live, a new study suggests. But treatment for opioid problems is especially scarce in states that may drop people from their Medicaid health insurance rolls — unless…
Details
CAMBRIDGE, MA — What drives a person to smoke cigarettes – and keeps one out of six U.S. adults addicted to tobacco use, at a cost of 480,000 premature deaths each year despite decades of anti-smoking campaigns? What role do emotions play in this addictive behavior? Why do some smokers puff more often and more…
Details
Have you ever played with a baby and felt a sense of connection, even though they couldn’t yet talk to you? New research suggests that you might quite literally be “on the same wavelength,” experiencing similar brain activity in the same brain regions. A team of Princeton researchers has conducted the first study of how…
Details
LEXINGTON, Ky. (Jan. 9, 2020) – The University of Kentucky recently received $3 million from the National Institute on Drug Abuse and National Institute on General Medical Sciences to fund new opioid-related research in the criminal justice system. Known as the Geographic variation in Addiction Treatment (GATE) study, the 5-year project is led by Carrie…
Details
MELBOURNE, Australia – In a promising discovery that could improve the clinical delivery of insulin for people living with diabetes, scientists have developed a non-fibrillating form of human insulin. Using a novel glycosylation technique, an international research team led by Associate Professor Akhter Hossain from the Florey Institute of Neuroscience and Mental Health, has successfully…
Details